These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms. Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres]. Korshunov AG; Sycheva RV Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Ghazvini S; Kroll S; Char DH; Frigillana H Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099 [TBL] [Abstract][Full Text] [Related]
7. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy. Grunnet ML; O'Neill A; Gilbert M; Hellman R Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748 [TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
10. AgNOR- and PCNA-studies in astrocytomas of the optic nerve. Patt S; Giraldo M; Martin H Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678 [TBL] [Abstract][Full Text] [Related]
11. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus]. Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772 [TBL] [Abstract][Full Text] [Related]
16. The significance of gemistocytes in astrocytoma. Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567 [TBL] [Abstract][Full Text] [Related]
17. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828 [TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis. Narita T; Funahashi H; Satoh Y; Takagi H Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256 [TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma. Malhan P; Husain N; Bhalla S; Gupta RK; Husain M Indian J Pathol Microbiol; 2010; 53(1):20-3. PubMed ID: 20090216 [TBL] [Abstract][Full Text] [Related]
20. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]